Reveal Pharmaceuticals, Inc. SBIR Phase I Award, September 2022
A SBIR Phase I contract was awarded to Reveal Pharmaceuticals in September, 2022 for $290,410.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Currently, there are no issues on this topic.
Find more entities like Reveal Pharmaceuticals, Inc. SBIR Phase I Award, September 2022
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
